166 results
8-K
EX-10.1
KA
Kineta Inc
24 Apr 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-10.2
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
8-K
EX-10.1
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
8-K
EX-10.1
KA
Kineta Inc
15 Dec 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
KA
Kineta Inc
17 Oct 23
Entry into a Material Definitive Agreement
8:32am
8-K
EX-10.1
mn4u42gy
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-10.1
tjmj2q2zfqmpsup gl
21 Jul 23
Entry into a Material Definitive Agreement
5:00pm
8-K/A
EX-10.1
g7hhfh5
2 Jun 23
Financial Statements and Exhibits
4:00pm
8-K
EX-10.1
bsz 6advn5h4bzew
30 May 23
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.2
emz7mlz
30 May 23
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10
m7kmpcdoax7byen
2 May 23
Entry into a Material Definitive Agreement
4:04pm
8-K
EX-10.1
ay5htz5zh yllar14pbx
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
8-K
EX-10.17
9vw72xvcpnq07wz3
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.6
egz2349mtqvd64utuz
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.15
1rxl4j1 jfbbn4n
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.16
kd6q 7wte
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.3
1vm0thzq
5 Dec 22
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta
9:27am
8-K
EX-10.1
627ybr1 isphlik9rcsu
5 Dec 22
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta
9:27am